Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-upBerit Jordan, Karin Jordan, Anita Margulies et al.|Annals of Oncology|2020Cited by 319
Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guideFlorian Scotté, Florian Strasser, Paolo Bossi et al.|Annals of Oncology|2018Cited by 169
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingJørn Herrstedt, Florian Scotté, Rebecca Clark-Snow et al.|ESMO Open|2024Cited by 141
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trialOlivier Mir, Étienne Minvielle, Delphine Mathivon et al.|Nature Medicine|2022Cited by 138
Pegylated liposomal doxorubicin-associated hand–foot syndrome: Recommendations of an international panel of expertsRoger von Moos, Axel Hauschild, Beat Thuerlimann et al.|European Journal of Cancer|2008Cited by 128